Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $105.52 -2.59%
EPS Growth %: +9.2%
Financial Fact:
Operating Earnings: 897M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.2%
Financial Fact:
Operating Earnings: 897M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q3 EPS of $1.30, in-line with the analyst estimate of $1.30. Revenue for the quarter came in at $11.37 billion versus the consensus estimate of $11.4 billion.
GUIDANCE:
Abbott sees FY2025 EPS of $5.12-$5.18, versus the consensus of $5.14.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
